secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001213900-23-042369
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive receives Nasdaq notice for failure to meet $35M market value requirement
--------------------------------------------------------------------------------

- Nasdaq notified Unicycive on May 17, 2023 that common stock MV fell below $35M for 30 consecutive business days.
- Company has 180 calendar days, until November 13, 2023, to regain compliance.
- If compliance not met by deadline, stock may be delisted; company can appeal to a Hearings Panel.
- Unicycive will monitor market value and evaluate options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023042369/0001213900-23-042369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023042369/ea179021-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-042369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer